Osseus Granted FDA Standalone Indication for Integrated ALIF with Alternative Fixation

Osseus Fusion Pisces Standalone

Osseus was granted what is reportedly the first-ever FDA standalone indication for an integrated Anterior Lumbar Interbody Fusion (ALIF) device utilizing alternative fixation without the need for supplemental fixation.

The primary goals of integrated fixation in ALIF interbodies are to prevent interbody expulsion and stabilize the spinal...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us